Table 1.
Demographics and disease characteristics at baseline.
| Characteristic | Number of Patients, n (% of Total) |
|---|---|
| Age | |
| ≥65 | 23 (39.7) |
| Male | 42 (72.4) |
| ECOG performance status | |
| 0 | 22 (37.9) |
| 1 | 29 (50.0) |
| 2 | 7 (12.1) |
| IMDC prognostic risk | |
| Favorable | 11 (19.0) |
| Intermediate | 29 (50.0) |
| Poor | 18 (31.0) |
| Pathology | |
| Clear cell | 41 (70.7) |
| Non-clear cell | 17 (29.3) |
| No. of organs with metastases | |
| 1 | 20 (34.5) |
| ≥2 | 38 (65.5) |
| Sites of metastasis | |
| Lung | 47 (81.0) |
| Lymph node | 17 (29.3) |
| Bone | 21 (36.2) |
| Liver | 6 (10.3) |
| Previous nephrectomy | 30 (51.7) |